NOA TRACKER
Track NIDDK Diabetes Research Center Funding.
DRCs drive breakthroughs, support new therapy development, and improve the lives of millions. Use NOA data to plan ahead.
Transforming lives through breakthrough treatments
Years of diabetes research excellence
NIDDK-funded Diabetes Research Centers
Researcher and trainee participants across programs
Diabetes Research Centers
These centers provide state-of-the-art resources, expertise, and collaborative environments that support innovative research across the spectrum of diabetes and its complications. Emphasis is placed on driving rapid progress from fundamental insights to real-world solutions, including prevention, treatment, and the search for a cure for diabetes.
A successful initiative that transformed the field
View NIDDK Data
Track FY25 distributions across all Diabetes Research Centers (DRC)
Explore Notice of Award (NOA) release timelines with valuable added context, including application and program type, organizational traits, state or region, and historical funding data for each center.
Strategic Planning & Benchmarking
Compare your center's funding timeline against those at peer institutions to establish realistic expectations and recognize potential delays early on. Filter by application type, geographic region, or funding amount to identify patterns that may affect programs like yours.
Historical Context
See past funding totals to understand how policy changes, budget cycles, and external factors affect cancer research funding over time. Compare current delays to historical norms to determine whether challenges are temporary disruptions or systemic issues requiring sustained advocacy.
Advocacy & Communication
Use concrete data to strengthen conversations with institutional leadership, legislators, and funding agencies. When you can show that similar centers have received NOAs in a particular timeline but yours is still experiencing a lengthy delay, you have evidence to support requests for bridge funding or policy changes.
Strategic Applications
How research administrators can use this data
Frequently asked questions
Currently, we only track the NIDDK-funded Diabetes Research Centers — all centers receiving P30 funding for diabetes research. These represent the premier diabetes research institutions in the United States and receive the most significant federal funding for diabetes research and treatment development. While there are excellent diabetes research programs at other institutions, the NIDDK-funded centers have a unique funding structure and reporting requirements that make them particularly suitable for this type of tracking.
We primarily track P30 Diabetes Research Center grants since these are the core funding mechanisms for DRCs. We don’t track every individual R01 or small grant at the moment. Our focus is on significant center-level funding when it’s substantial enough to impact operations and strategic, center-level decision making.
Our primary source is the NIH RePORTER database, which we access weekly. We also monitor NIDDK announcements, institutional press releases, and official NOA documents when they’re publicly available. We don’t rely on rumors, social media, or unofficial sources. If we can’t verify information through official channels, we mark it as pending internally until we can confirm the details. This conservative approach ensures our data is reliable.
We update our Diabetes Research Center funding data every Saturday after the NIH RePORTER database refreshes. Unlike automated feeds that can miss nuances or contain errors, we manually verify each NOA release and cross-reference it with official sources. This means you get reliable, human-checked intelligence rather than raw data dumps. Our weekly schedule also ensures you’re never more than a few days behind the latest funding announcements.
Yes, that is our intent for providing the NOA Tracker. We have provided buttons within each page that enable CSV downloads of the complete dataset, updated weekly. The download includes all the fields you see in the tracker plus some additional metadata that might be useful for analysis. You’re free to use this data for internal planning, presentations to leadership, or advocacy efforts. We just ask that you credit the source if you share the data publicly or use it in publications.
In the event that an error is found, we request that you reach out to us immediately through our contact form. We take data accuracy seriously and want to correct any errors quickly. When you contact us, please include the specific grant number, the error you’ve identified, and any supporting documentation you can provide. We typically investigate and respond to error reports within 48 hours. Your feedback helps us maintain the quality that makes this tracker valuable for the entire community.
No, the NOA Tracker is completely free to access and use. We believe funding transparency benefits the entire diabetes research community, so we don’t gate the data behind paywalls or registration requirements. You can bookmark the page, download the data, and share it with colleagues without any restrictions. Our goal is to support diabetes research excellence, not to create barriers to information access.
Diabetes research requires long-term planning and significant infrastructure investment to develop new treatments and improve patient care. When funding is delayed or uncertain, it impacts everything from hiring decisions to equipment purchases to clinical trial protocols. By tracking funding patterns, Diabetes Research Center administrators can plan more effectively, benchmark against peers, and advocate for predictable funding cycles. This transparency also helps the broader research community understand funding trends and challenges.
Questions? We'd love to connect.
Ask about the NOA Tracker, how we gather the data, or anything else. Our experts are standing by, ready to help.
We believe research is the greatest platform for progress.
We are passionate proponents of _______, committed to doing well by all of our stakeholders — our partners, employees, communities, the planet, and society as a whole. And we lead by example, spearheading initiatives in philanthropy, racial equality and justic, climate action and advocacy, and the ethical and humane use of technology.